# 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/6-months-versus-12-months-of-adjuvant-trastuzumab-in-early-breast-cancer-phare/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xavier Pivot,Gilles Romieu,Marc Debled,Jean‐Yves Pierga,Pierre Kerbrat,Thomas Bachelot,Alain Lortholary,Marc Espié,P. Fumoleau,Daniel Serin,Jean-Philippe Jacquin,Christelle Jouannaud,María Rios,Sophie Abadie‐Lacourtoisie,Laurence Venat‐Bouvet,Laurent Cany,Stéphanie Catala,David Khayat,Laëtitia Gambotti,Iris Pauporté,Céline Faure-Mercier,Sophie Paget‐Bailly,Julie Henriques,Jean Marie Grouin,Christine Piprot,L. Cals,L. Chaigneau,Francesca Demarchi,Trung Van Nguyen,Ulrike Stein,Cristian Villanueva,Bréau Jl,A.K. Chouahnia,Pierre Saintigny,François Boué,P deSaint-Hilaire,I Guimont,Nathalie Grossat,B. Valenza,E. Lévy,Jacques Médioni,Catherine Delbaldo,Jean‐Christophe Grenier,Damien Pouessel,Sandrine Lavau‐Denès,Claire Falandry,Cécile Fournel-Federico,Gilles Freyer,Sophie Tartas,V. Trillet-Lenoir,F. Bons,G Auclerc,Stéphanie Chièze,Nadia Raban,C. Tournigand,S. Trager-Maury,Guilhem Bousquet,C. Cuvier,Sylvie Giacchetti,Adam Hocini,C. Lemaignan,JL Misset,D. Avenin,C Beerblock,Joseph Gligorov,P. Rivera,Henri Roché,Philippe Bougnoux,Nawale Hajjaji,Olivier Capitain,R. Delva,P. Maillart,P Soulié,Hervé Bonnefoi,M Durand,Nicolas Madranges,L. Mauriac,P. Chollet,AF Dillies,Xavier Durando,J P Ferrière,C Mouret-Reynier,Nabholtz Jm,Isabelle Van Praagh,P. Cottu,Véronique Dièras,Axel Durieux,M Galotte,V. Girre,Sébastien Henry,Ida Iurisci,M Jouve,Valérie Laurence,L. Mignot,Sophie Piperno‐Neumann,Patricia Tresca,Bruno Coudert,Emmanuelle Ferrant,F. Mayer,AC Vanneuville |
| Citations | 129 |
| DOI | 10.1016/s0140-6736(19)30653-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2948720210 |
| PMID | 31178155 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Anelia Dietmann](https://scholariq.org/researchers/anelia-dietmann/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.